[ad_1]
The world waits for an effective vaccine against Corona
In the framework of efforts to achieve a more effective and advanced formula for the Corona vaccine, the developers of the Russian vaccine “Sputnik 5” and British “AstraZeneca” revealed the exchange of scientific data related to the emerging vaccine against Corona virus among them, to work on finding ways to develop the potential vaccine. According to the “Washington Post”.
Efforts are still being made, according to the newspaper, to develop and obtain a second generation of the anti-corona vaccine formula.
Research by the two companies aims to test new vaccine formulations using cold viruses, according to a statement issued by AstraZeneca.
Sputnik’s developers rely on two injections, one based on the common cold virus and the other based on viruses that infect the glands.
As for AstraZeneca, its vaccine is based on cold viruses that usually infect chimpanzees.
According to AstraZeneca, “it will soon begin to explore (about the vaccine) in Russia to conclude whether it is possible to successfully combine two adenovirus vaccines”
Russia said AstraZeneca agreed to explore the use of Sputnik 5 as part of efforts to produce a modified vaccine.
On Tuesday Britain began vaccinating the first batch of 800,000 people, prioritizing the elderly in nursing homes, after it gave approval for the Pfizer-Bionic vaccine.
The Washington Post claimed in another report that this week would have seen the start of the first phase of vaccination with the Sputnik 5 vaccine in Russia, but the Russians did not accept the vaccine that was approved without completing the human testing phase.
